(19)
(11)EP 3 111 985 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
13.01.2021 Bulletin 2021/02

(21)Application number: 15752249.1

(22)Date of filing:  18.02.2015
(51)International Patent Classification (IPC): 
A61M 37/00(2006.01)
A61L 31/06(2006.01)
(86)International application number:
PCT/JP2015/000761
(87)International publication number:
WO 2015/125475 (27.08.2015 Gazette  2015/34)

(54)

HOLLOW NEEDLE-SHAPED BODY MANUFACTURING METHOD AND HOLLOW NEEDLE-SHAPED BODY

HERSTELLUNGSVERFAHREN EINES HOHLEN NADELFÖRMIGEN KÖRPERS UND HOHLER NADELFÖRMIGER KÖRPER

PROCÉDÉ DE FABRICATION D'UN CORPS EN FORME D'AIGUILLE CREUSE ET CORPS EN FORME D'AIGUILLE CREUSE


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 24.02.2014 JP 2014033063

(43)Date of publication of application:
04.01.2017 Bulletin 2017/01

(73)Proprietor: Toppan Printing Co., Ltd.
Tokyo 110-0016 (JP)

(72)Inventor:
  • SUMIDA, Tomoya
    Tokyo 110-0016 (JP)

(74)Representative: TBK 
Bavariaring 4-6
80336 München
80336 München (DE)


(56)References cited: : 
WO-A1-2014/017561
JP-A- 2010 058 384
JP-A- 2011 072 695
JP-A- 2014 023 697
JP-A- 2009 072 271
JP-A- 2010 063 666
JP-A- 2012 143 423
  
      
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


    Description

    [Technical Field]



    [0001] The present invention relates to a method for manufacturing a hollow needle-shaped body and relates to a hollow needle-shaped body.

    [Background Art]



    [0002] In recent years, a drug administration method as an alternative to injection has been attracting attention. The method uses an array made up of a plurality of needle-shaped bodies of a micron order of size to pierce the skin, and allows for direct administration of the drug into the skin.

    [0003] The needle-shaped body must be made of a material which is harmless to the body even if the needle-shaped body is broken and remains in the body. Materials with potential for use in the needle-shaped body include biocompatible resins such as medical grade silicone, maltose, polylactic acid, polyglycolic acid and dextran (for example, see JP 2005-21677 A).

    [0004] Further, the aforementioned needle-shaped body may also be a hollow type having a through hole (hereinafter, also referred to as "hollow needle-shaped body"). For example, a method for forming the through hole in the hollow needle-shaped body is disclosed which includes forming the needle-shaped body having a substrate and a projection formed on one surface of the substrate from a resin material by a thermal imprint method, and then forming the through hole that penetrates through the substrate and the projection in a thickness direction of the substrate by radiating a laser beam onto the other surface of the substrate (for example, JP 2011-72695 A) .

    [0005] JP 2010 058384 A, JP 2014 023697 A and WO 2014/017561 A1 relate to similar hollow needle-shaped bodies. In particular, JP 2014 023697 A and WO 2014/017561 A1 relate to methods for manufacturing a hollow needle-shaped body according to the preamble of claim 1.

    [Summary of the Invention]


    [Technical Problem]



    [0006]  However, the above conventional technique which forms the through hole that penetrates through the substrate and the projection by radiating a laser beam may have difficulty in forming the through hole due to an effect of heat generated by a laser beam. Further, if the through hole is formed, there may be defects in the shape of the through hole such as a lack of sharpness on the edge of the through hole.

    [0007] The present invention has been made to overcome the above problems, and has an object to provide a method for manufacturing a hollow needle-shaped body having a through hole of a good shape and to provide a hollow needle-shaped body.

    [Solution to Problem]



    [0008] An aspect of the present invention is characterized by including: a first step of manufacturing a needle-shaped body having a substrate and a projection formed on one surface of the substrate; and a second step of forming a through hole that penetrates through the substrate and the projection by radiating a laser beam onto the other surface of the substrate after the first step, wherein the substrate and the projection are made of crystallized polyglycolic acid.

    [Advantageous Effects of Invention]



    [0009] According to an aspect of the present invention, the substrate and the projection are formed of crystallized polyglycolic acid which is suitable for laser processing. Accordingly, when the through hole that penetrates through the substrate and the projection is formed by radiating a laser beam, the through hole can be formed in a good shape.

    [Brief Description of the Drawings]



    [0010] 

    Fig. 1 is a cross sectional view which shows a configuration of a hollow needle-shaped body according to an embodiment of the present invention.

    Fig. 2 is a cross sectional view which shows a method for manufacturing the hollow needle-shaped body according to an embodiment of the present invention.

    Fig. 3 is a cross sectional view which shows a modification example of the hollow needle-shaped body according to an embodiment of the present invention.


    [Description of Embodiments]



    [0011] In the following detailed description, many specific details are set forth in order to provide a thorough understanding of the embodiments of the present invention. However, it should be obvious that those specific details are not necessarily indispensable to carry out one or more embodiments. Furthermore, for simplicity of illustration, known configurations and devices are schematically shown.

    [0012] With reference to the drawings, embodiments of the present invention will be described.

    (Configuration)



    [0013] First, a configuration of a hollow needle-shaped body 1 will be described.

    [0014] As shown in Fig. 1, the hollow needle-shaped body 1 includes a plate-shaped substrate 2, and a projection 3 formed on one surface (hereinafter, also referred to as "projection forming surface") of the substrate 2. The shape of the projection 3 is not specifically limited. For example, it may be conical shape, polygonal pyramid shape, round columnar shape or polygonal columnar shape. Furthermore, those shapes may be combined, for example, into a pencil-like shape, which is made up of a columnar shape and a conical shape stacked on the substrate 2 in this order. The hollow needle-shaped body 1 has a through hole 4 that penetrates through the substrate 2 and the projection 3 in a thickness direction of the substrate 2. The hollow needle-shaped body 1 (substrate 2, projection 3) is made of crystallized polyglycolic acid.

    [0015] As described above, the hollow needle-shaped body 1 in this embodiment is made of biodegradable and biocompatible crystallized polyglycolic acid (that is, polyglycolic acid). Accordingly, even if the hollow needle-shaped body 1 is broken and remains in the body, it may cause less harm to the body.

    [0016] The projection 3 of the hollow needle-shaped body 1 according to the present embodiment preferably has a height h in the range between 0.5 mm or more and 2.0 mm or less, more preferably, in the range between 0.7 mm or more and 1.5 mm or less. The term "height h" as used herein refers to the height from the surface of the substrate 2 on which the projection 3 is formed to the apex of the projection 3.

    [0017] Further, when the maximum diameter of the projection 3 at a connection between the projection 3 and the substrate 2 of the hollow needle-shaped body 1 is defined as a maximum diameter a, the height h divided by the maximum diameter a, a value h/a, is preferably in the range between 1.1 or more and 5 or less.

    [0018] Furthermore, a plurality of projections 3 may be provided on the substrate 2. The number of projections 3 on the substrate 2 is preferably in the range between 1 or more and 50 or less, more preferably, in the range between 1 or more and 10 or less. The plurality of projections 3 on the substrate 2 can provide the advantageous effect of pain mitigation during drug administration, but may cause leakage of the drug during drug administration.

    (Manufacturing Method)



    [0019] Next, a method for manufacturing the hollow needle-shaped body 1 will be described.

    [0020] As shown in Fig. 2(a), a step (hereinafter, referred to as "first step") is first performed to manufacture a needle-shaped body 5 having the substrate 2 and the projection 3 formed on one surface (projection forming surface) of the substrate 2. A variety of known methods can be used to manufacture the needle-shaped body 5. For example, the methods include injection molding, compression molding, extrusion molding, thermal imprinting and hot embossing.

    [0021] Further, the material for the needle-shaped body 5 (substrate 2, projection 3) is crystallized polyglycolic acid. Polyglycolic acid is a resin that relatively easily crystallizes. Crystallization methods include, for example, slowly cooling after heat molding, keeping at around the crystallization temperature (approximately 100 to 120°C) for a certain period of time during cooling, and applying heat treatment at around the crystallization temperature after heat molding. Crystallization of polyglycolic acid can be seen by observing the color tone. Polyglycolic acid is transparent when it is not crystallized, and is not transparent (is white in color) when it is crystallized.

    [0022] Furthermore, the crystallization of polyglycolic acid in this embodiment can be determined by measuring the degree of crystallization by using differential scanning calorimetry (DSC). When the degree of crystallization observed by differential scanning calorimetry (DSC) is 40% or more, the hollow needle-shaped body 1 made of polyglycolic acid according to the present embodiment is determined to be "crystallized". Although a higher degree of crystallization is preferable, the degree of crystallization is preferably not more than 90% considering manufacturing processes.

    [0023] As shown in Fig. 2(b), the first step is followed by a step (hereinafter, referred to as "second step") of forming the through hole 4 that penetrates through the substrate 2 and the projection 3 in a thickness direction of the substrate 2 by radiating a laser beam onto the other surface (hereinafter, referred to as "non-projection forming surface") of the substrate 2. According to the present embodiment, the hollow needle-shaped body 1 having the through hole 4 is thus manufactured.

    [0024] The inventor of the present invention has thoroughly studied to find that the through hole 4 can be formed in a good shape when a laser beam is radiated to crystallized polyglycolic acid, while the through hole 4 has defects in shape when a laser beam is radiated to non-crystallized polyglycolic acid. For example, there may be difficulty in forming the through hole 4 due to an effect of heat or the through hole 4 may have a lack of sharpness on the edge when it is formed.

    [0025] According to the present embodiment as described above, the substrate 2 and the projection 3 are formed of crystallized polyglycolic acid which is suitable for laser processing. Accordingly, when the through hole 4 is formed in the substrate 2 and the projection 3 by radiating a laser beam, the through hole 4 can be formed in a good shape. In addition, since the laser beam is converged by a lens (not shown in the figure), a tapered cross section is formed. The cross sectional area of the through hole 4 decreases from the non-projection forming surface to the projection forming surface. As a result, the hollow needle-shaped body 1 can be formed in the shape suitable for liquid drug administration into the skin.

    [0026] The type of the laser beam is not specifically limited. For example, an excimer laser beam which can be efficiently absorbed in the resin material and suppress the effect of heat can be advantageously used.

    [0027] Although the through hole 4 in the example of the present embodiment is formed to penetrate the side surface of the projection 3 by radiating a laser beam (see Fig. 2(b)), other configurations are also possible. For example, as shown in Fig. 3, a through hole 4 that penetrates the apex of the projection 3 can be formed. Note that the hollow needle-shaped body 1 having the through hole 4 that penetrates the side surface of the projection 3 is more preferable than the hollow needle-shaped body 1 having the through hole 4 that penetrates the apex of the projection 3 in piercing ability of the hollow needle-shaped body 1 into the skin.

    (Usage)



    [0028] An example of usage of the hollow needle-shaped body 1 according to the present embodiment will be described.

    [0029] In the usage of the hollow needle-shaped body 1 according to the present embodiment, that is, intradermal drug administration by using the hollow needle-shaped body 1, the hollow needle-shaped body 1 is first pierced into the skin. Then, a drug is administered into the skin via the through hole 4 of the hollow needle-shaped body 1. After that, the hollow needle-shaped body 1 pierced into the skin is withdrawn.

    [0030] The above intradermal administration method is advantageous over other administration methods in that the liquid drug can be used in a similar manner to the conventional injection, the dose of drug can be increased, the dose of drug can be accurately controlled, and so on.

    [0031] In the conventional drug administration method, a drug such as a vaccine is administered into the body by injection. Although injection is a safe administration method, it often involves severe pain when the injection needle is deeply pierced into the body to deliver the drug into the subcutaneous tissue. Further, in developing countries and the like, there are issues such as infection by reuse of injection needles and a high risk of occurrence of needle stick injuries.

    (Advantageous Effect of Embodiment)



    [0032] According to the present embodiment, the method for manufacturing the hollow needle-shaped body 1, and the hollow needle-shaped body 1, have the following advantageous effects.
    1. (1) The method for manufacturing the hollow needle-shaped body 1 according to the present embodiment includes a first step of manufacturing the needle-shaped body 5 having the substrate 2 and the projection 3 formed on one surface (projection forming surface) of the substrate 2, and a second step of forming the through hole 4 that penetrates through the substrate 2 and the projection 3 by radiating a laser beam onto the other surface (non-projection forming surface) of the substrate 2. The substrate 2 and the projection 3 are made of crystallized polyglycolic acid.
      In this configuration, the substrate 2 and the projection 3 are formed of crystallized polyglycolic acid which is suitable for laser processing. Accordingly, when the through hole 4 that penetrates through the substrate 2 and the projection 3 is formed by radiating a laser beam, the through hole 4 can be formed in a good shape.
    2. (2) The method for manufacturing the hollow needle-shaped body 1 according to the present embodiment uses an excimer laser as a laser beam.
      In this configuration, an excimer laser beam which can be efficiently absorbed in the resin material and suppress the effect of heat is radiated. Accordingly, the through hole 4 can be appropriately formed in the substrate 2 and the projection 3.
    3. (3) In the method for manufacturing the hollow needle-shaped body 1 according to the present embodiment, the needle-shaped body 5 which is necessary for manufacturing the hollow needle-shaped body 1 is formed by transfer molding such as injection molding, imprinting and casting.
      In this configuration, the hollow needle-shaped body 1 which is a micro structure can be manufactured at low cost in mass production.
    4. (4) The hollow needle-shaped body 1 according to the present embodiment includes the substrate 2, the projection 3 formed on one surface (projection forming surface) of the substrate 2, and the through hole 4 which penetrates through the substrate 2 and the projection 3, wherein the substrate 2 and the projection 3 are made of crystallized polyglycolic acid.
      In this configuration, the hollow needle-shaped body 1 is made of biodegradable and biocompatible polyglycolic acid. Accordingly, even if the hollow needle-shaped body 1 is broken and remains in the body, it may cause less harm to the body.
    5. (5) The projection 3 of the hollow needle-shaped body 1 according to the present embodiment has the height h, which is for example in the range between 0.5 mm or more and 2.0 mm or less. Further, the height h divided by the maximum diameter a of the projection 3, the value (h/a), is for example in the range between 1.1 or more and 5 or less.
      In general, the shape of the needle-shaped body needs to have a thinness and a tip angle sufficient for piercing the skin and a length sufficient for intradermal drug delivery (that is, sufficient height h). Accordingly, the projection 3 desirably has a length that penetrates through the stratum corneum which is the outermost layer of the skin but does not reach the nerve plexus, which is the height being specifically in the order of several hundreds of micrometers to several millimeters. Further, the needle-shaped body desirably has a diameter in the order of several tens of micrometers to several hundreds of micrometers.
      In the hollow needle-shaped body 1 according to the present embodiment, it is possible to mitigate the pain felt by a patient during piercing the projection 3 into the skin since the length of the projection 3 is controlled not to reach the nerve cells in the dermis layer. Further, when vaccine is intradermally administered using the hollow needle-shaped body 1, the amount of vaccine used can be reduced compared with subcutaneous injection since antigen presenting cells are abundant in the skin.
    6. (6) The hollow needle-shaped body 1 according to the present embodiment has the degree of crystallization of crystallized polyglycolic acid of 40% or more.
      In this configuration, a sufficient strength can be applied to the hollow needle-shaped body 1.
    7. (7) The hollow needle-shaped body 1 according to the present embodiment is a needle-shaped body having a through hole 4, and can be used for intradermal administration by piercing the needle-shaped body into the skin and delivering the drug into the skin via the through hole 4. The intradermal administration method is advantageous over other administration methods in that the liquid drug can be used in a similar manner to the conventional injection, the dose of drug can be increased, the dose of drug can be accurately controlled, and so on.

    Example



    [0033] Examples of the hollow needle-shaped body 1 according to the present embodiment and a comparative example will be described.

    (Example 1)



    [0034] First, as shown in Fig. 2(a), the needle-shaped body 5 which was made of crystallized polyglycolic acid and included the substrate 2 and the projection 3 formed on one surface (projection forming surface) of the substrate 2 was fabricated by a thermal imprint method by using a nickel mold which was manufactured by machining. The substrate 2 was disk-shaped with a diameter of 10 mm and a thickness of 700 µm. The projection 3 was a rectangular pyramid shape with the height h of 800 µm. Furthermore, in the needle-shaped body 5, the projection 3 at the connection between the projection 3 and the substrate 2 had a square shape and a length of each side of the square was 350 µm. In the thermal imprint process, the needle-shaped body 5 was kept at around the crystallization temperature (110°C) for a period of 5 minutes during cooling.

    [0035] The entire needle-shaped body 5 thus fabricated in Example 1 was white in color. This revealed that polyglycolic acid was crystallized. Further, in the needle-shaped body 5 according to Example 1, the degree of crystallization of polyglycolic acid measured by using differential scanning calorimetry (DSC) was 55%.

    [0036] After the needle-shaped body 5 was fabricated, the through hole 4 that penetrated through the substrate 2 and the projection 3 was formed as shown in Fig. 2(b) by radiating a KrF excimer laser beam from the non-projection forming surface. Thus, the hollow needle-shaped body 1 having the through hole 4 was formed. Further, the through hole 4 had a diameter of 100 µm on the non-projection forming surface, and 50 µm on the projection forming surface. The through hole 4 had a good shape with a sharp edge both on the non-projection forming surface and projection forming surface.

    (Example 2)



    [0037] First, as shown in Fig. 2(a), the needle-shaped body 5 which was made of crystallized polyglycolic acid and included the substrate 2 and the projection 3 formed on one surface (projection forming surface) of the substrate 2 was fabricated by a thermal imprint method by using a nickel mold which was manufactured by machining. The substrate 2 was disk-shaped with a diameter of 10 mm and a thickness of 700 µm. The projection 3 was a rectangular pyramid shape with the height h of 800 µm. Furthermore, in the needle-shaped body 5, the projection 3 at the connection between the projection 3 and the substrate 2 had a square shape and the length of each side of the square was 350 µm. In the thermal imprint process, the needle-shaped body 5 was kept at around the crystallization temperature (110°C) for a period of 15 minutes during cooling.

    [0038] The entire needle-shaped body 5 thus fabricated in Example 2 was white in color. This revealed that polyglycolic acid was crystallized. Further, in the needle-shaped body 5 according to Example 2, the degree of crystallization of polyglycolic acid measured by using differential scanning calorimetry (DSC) was 80%.

    [0039] After the needle-shaped body 5 was fabricated, the through hole 4 that penetrates through the substrate 2 and the projection 3 was formed as shown in Fig. 2(b) by radiating a KrF excimer laser beam from the non-projection forming surface. Thus, the hollow needle-shaped body 1 having the through hole 4 was formed. Further, the through hole 4 had a diameter of 100 µm on the non-projection forming surface, and 50 µm on the projection forming surface. The through hole 4 had a good shape with a sharp edge both on the non-projection forming surface and projection forming surface.

    (Comparative Example)



    [0040] As a comparative example, the needle-shaped body 5 was fabricated in a similar manner to Example 1 except for "keeping at around the crystallization temperature (110°C) for a period of 5 minutes during cooling" in Example 1.

    [0041] Specifically, as shown in Fig. 2(a), the needle-shaped body 5 which was made of crystallized polyglycolic acid and included the substrate 2 and the projection 3 formed on one surface (projection forming surface) of the substrate 2 was fabricated by a thermal imprint method by using a nickel mold which was manufactured by machining. The substrate 2 was disk-shaped with a diameter of 10 mm and a thickness of 700 µm. The projection 3 was a rectangular pyramid shape with the height h of 800 µm. Furthermore, in the needle-shaped body 5, the projection 3 at the connection between the projection 3 and the substrate 2 had a square shape and the length of each side of the square was 350 µm.

    [0042] The entire needle-shaped body 5 thus fabricated in Comparative Example was transparent. Further, in the needle-shaped body 5 according to Comparative Example, the degree of crystallization of polyglycolic acid measured by using differential scanning calorimetry (DSC) was 13%.

    [0043] After the needle-shaped body 5 was fabricated, the through hole 4 that penetrated through the substrate 2 and the projection 3 was formed as shown in Fig. 2(b) by radiating a KrF excimer laser beam from the non-projection forming surface. Thus, the hollow needle-shaped body 1 having the through hole 4 was formed. In the hollow needle-shaped body 1 thus obtained, the through hole 4 had defects in shape with the edge widely expanded both on the non-projection forming surface and projection forming surface.

    [0044] The present invention has been described above with reference to the specific embodiment. However, the above description is not intended to limit the present invention. When reading the description of the present invention, a person having ordinary skill in the art would obviously understand other embodiments of the present invention along with various modifications of the embodiment disclosed above.

    Reference Signs List



    [0045] 
    1
    Hollow needle-shaped body
    2
    Substrate
    3
    Projection
    4
    Through hole
    5
    Needle-shaped body



    Claims

    1. A method for manufacturing a hollow needle-shaped body (1), the method comprising:

    a first step of manufacturing the needle-shaped body having a substrate (2) and a projection (3) formed on one surface of the substrate (2); and

    a second step of forming a through hole (4) that penetrates through the substrate (2) and the projection (3) by radiating a laser beam onto the other surface of the substrate (2) after the first step,

    characterized in that

    the substrate (2) and the projection (3) are made of crystallized polyglycolic acid.


     
    2. The method for manufacturing a hollow needle-shaped body (1) according to claim 1, characterized in that the laser beam is an excimer laser beam.
     
    3. The method for manufacturing a hollow needle-shaped body (1) according to claim 1 or 2, characterized in that a height from one surface of the substrate (2) to an apex of the projection (3) is in a range between 0.5 mm or more and 2.0 mm or less.
     
    4. The method for manufacturing a hollow needle-shaped body (1) according to claim 3, characterized in that the height divided by a maximum diameter of the projection (3) at a connection between the projection (3) and the substrate (2) is in a range between 1.1 or more and 5 or less.
     
    5. The method for manufacturing a hollow needle-shaped body (1) according to any one of claims 1 to 4, characterized in that a degree of crystallization of the crystallized polyglycolic acid is 40% or more.
     
    6. The method for manufacturing a hollow needle-shaped body (1) according to any one of claims 1 to 5, characterized in that the polyglycolic acid is crystallized before the second step of forming a through hole (4).
     
    7. A hollow needle-shaped body (1) comprising:

    a substrate;

    a projection formed on one surface of the substrate; and

    a through hole that penetrates through the substrate and the projection, wherein

    the substrate and the projection are made of crystallized polyglycolic acid, and

    the hollow needle-shaped body (1) is manufactured by a method according to any one of claims 1 to 6.


     
    8. The hollow needle-shaped body (1) according to claim 7, characterized in that a height from one surface of the substrate (2) to an apex of the projection (3) is in a range between 0.5 mm or more and 2.0 mm or less.
     
    9. The hollow needle-shaped body (1) according to claim 8, characterized in that the height divided by a maximum diameter of the projection (3) at a connection between the projection (3) and the substrate (2) is in a range between 1.1 or more and 5 or less.
     
    10. The hollow needle-shaped body (1) according to any one of claims 7 to 9, characterized in that a degree of crystallization of the crystallized polyglycolic acid is 40% or more.
     
    11. The hollow needle-shaped body (1) according to any one of claims 7 to 10, characterized in that a cross sectional area of the through hole (4) decreases from the non-projection forming surface to the projection forming surface.
     


    Ansprüche

    1. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1), wobei das Verfahren aufweist:

    einen ersten Schritt zum Herstellen des nadelförmigen Körpers, der einen Träger (2) und einen an einer Fläche des Trägers (2) ausgebildeten Vorsprung (3) hat; und

    einen zweiten Schritt zum Ausbilden eines Durchgangslochs (4), das den Träger (2) und den Vorsprung (3) durchdringt, durch Ausstrahlen eines Laserstrahls auf die andere Fläche des Trägers (2) nach dem ersten Schritt,

    dadurch gekennzeichnet, dass

    der Träger (2) und der Vorsprung (3) aus einer kristallisierten Polyglycolsäure gefertigt sind.


     
    2. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1) gemäß Anspruch 1, dadurch gekennzeichnet, dass der Laserstrahl ein Excimerlaserstrahl ist.
     
    3. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1) gemäß Anspruch 1 oder 2, dadurch gekennzeichnet, dass eine Höhe von einer Fläche des Trägers (2) zu einer Spitze des Vorsprungs (3) in einem Bereich zwischen 0,5 mm oder mehr und 2,0 mm oder weniger ist.
     
    4. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1) gemäß Anspruch 3, dadurch gekennzeichnet, dass die Höhe geteilt durch einen maximalen Durchmesser des Vorsprungs (3) an einer Verbindung zwischen dem Vorsprung (3) und dem Träger (2) in einem Bereich zwischen 1,1 oder mehr und 5 oder weniger ist.
     
    5. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1) gemäß einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass ein Kristallisierungsgrad der kristallisierten Polyglycolsäure 40% oder mehr ist.
     
    6. Verfahren zum Herstellen eines hohlen, nadelförmigen Körpers (1) gemäß einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, dass die Polyglycolsäure vor dem zweiten Schritt zum Ausbilden eines Durchgangslochs (4) kristallisiert wird.
     
    7. Hohler, nadelförmiger Körper (1), der aufweist:

    einen Träger;

    einen an einer Fläche des Trägers ausgebildeten Vorsprung; und

    ein Durchgangsloch, das den Träger und den Vorsprung durchdringt, wobei

    der Träger und der Vorsprung aus kristallisierter Polyglycolsäure gefertigt sind, und

    der hohle, nadelförmige Körper (1) durch ein Verfahren gemäß einem der Ansprüche 1 bis 6 hergestellt ist.


     
    8. Hohler, nadelförmiger Körper (1) gemäß Anspruch 7, dadurch gekennzeichnet, dass eine Höhe von einer Fläche des Trägers (2) zu einer Spitze des Vorsprungs (3) in einem Bereich zwischen 0,5 mm oder mehr und 2,0 mm oder weniger ist.
     
    9. Hohler, nadelförmiger Körper (1) gemäß Anspruch 8, dadurch gekennzeichnet, dass die Höhe geteilt durch einen maximalen Durchmesser des Vorsprungs (3) an einer Verbindung zwischen dem Vorsprung (3) und dem Träger (2) in einem Bereich zwischen 1,1 oder mehr und 5 oder weniger ist.
     
    10. Hohler, nadelförmiger Körper (1) gemäß einem der Ansprüche 7 bis 9, dadurch gekennzeichnet, dass ein Kristallisierungsgrad der kristallisierten Polyglycolsäure 40% oder mehr ist.
     
    11. Hohler, nadelförmiger Körper (1) gemäß einem der Ansprüche 7 bis 10, dadurch gekennzeichnet, dass sich eine Querschnittsfläche des Durchgangslochs (4) von der Fläche, an der der Vorsprung nicht ausgebildet ist, zu der Fläche verringert, an der der Vorsprung ausgebildet ist.
     


    Revendications

    1. Procédé pour fabriquer un corps en forme d'aiguille creuse (1), le procédé comprenant :

    une première étape de fabrication du corps en forme d'aiguille ayant un substrat (2) et une saillie (3) formée sur une surface du substrat (2) ; et

    une deuxième étape de formation d'un trou traversant (4) qui pénètre à travers le substrat (2) et la saillie (3) par irradiation d'un faisceau laser sur l'autre surface du substrat (2) après la première étape,

    caractérisé en ce que le substrat (2) et la saillie (3) sont faits en poly(acide glycolique) cristallisé.


     
    2. Procédé pour fabriquer un corps en forme d'aiguille creuse (1) selon la revendication 1, caractérisé en ce que le faisceau laser est un faisceau laser à excimères.
     
    3. Procédé pour fabriquer un corps en forme d'aiguille creuse (1) selon la revendication 1 ou 2, caractérisé en ce que la hauteur allant de la surface du substrat (2) à l'apex de la saillie (3) est située dans la plage comprise entre 0,5 mm ou plus et 2,0 mm ou moins.
     
    4. Procédé pour fabriquer un corps en forme d'aiguille creuse (1) selon la revendication 3, caractérisé en ce que la hauteur divisée par le diamètre maximal de la projection (3) au niveau de la connexion entre la saillie (3) et le substrat (2) est située dans la plage comprise entre 1,1 ou plus et 5 ou moins.
     
    5. Procédé pour fabriquer un corps en forme d'aiguille creuse (1) selon l'une quelconque des revendications 1 à 4, caractérisé en ce que le degré de cristallisation du poly(acide glycolique) cristallisé est de 40 % ou plus.
     
    6. Procédé pour fabriquer un corps en forme d'aiguille creuse (1) selon l'une quelconque des revendications 1 à 5, caractérisé en ce que le poly(acide glycolique) est cristallisé avant la deuxième étape de formation d'un trou traversant (4).
     
    7. Corps en forme d'aiguille creuse (1) comprenant :

    un substrat ;

    une saillie formée sur une surface du substrat ; et

    un trou traversant qui pénètre à travers le substrat et la saillie,

    dans lequel

    le substrat et la saillie sont faits en poly(acide glycolique) cristallisé, et

    le corps en forme d'aiguille creuse (1) est fabriqué par un procédé selon l'une quelconque des revendications 1 à 6.


     
    8. Corps en forme d'aiguille creuse (1) selon la revendication 7, caractérisé en ce que la hauteur allant de la surface du substrat (2) à l'apex de la saillie (3) est située dans la plage comprise entre 0,5 mm ou plus et 2,0 mm ou moins.
     
    9. Corps en forme d'aiguille creuse (1) selon la revendication 8, caractérisé en ce que la hauteur divisée par le diamètre maximal de la projection (3) au niveau de la connexion entre la saillie (3) et le substrat (2) est située dans la plage comprise entre 1,1 ou plus et 5 ou moins.
     
    10. Corps en forme d'aiguille creuse (1) selon l'une quelconque des revendications 7 à 9, caractérisé en ce que le degré de cristallisation du poly(acide glycolique) cristallisé est de 40 % ou plus.
     
    11. Corps en forme d'aiguille creuse (1) selon l'une quelconque des revendications 7 à 10, caractérisé en ce que la superficie en coupe transversale du trou traversant (4) diminue à partir de la surface ne formant pas une saillie vers la surface formant une saillie.
     




    Drawing











    Cited references

    REFERENCES CITED IN THE DESCRIPTION



    This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

    Patent documents cited in the description